Zydus Lifesciences Limited has announced a further extension for the acquisition of the API business of Sterling Biotech Limited (SBL). The transaction, initially expected to close by December 31, 2024, and later extended to December 31, 2025, has now had its closing date extended to June 30, 2026. This extension is due to SBL's ongoing process of fulfilling certain conditions precedent outlined in the Business Transfer Agreement (BTA). The Company and SBL have mutually agreed to this revised timeline, with the transaction now anticipated to be completed on or before June 30, 2026. This follows previous intimations regarding the BTA execution and earlier extensions.